Arihiro Kiyosue

3.4k total citations · 1 hit paper
72 papers, 1.2k citations indexed

About

Arihiro Kiyosue is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arihiro Kiyosue has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arihiro Kiyosue's work include Lipoproteins and Cardiovascular Health (14 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Diabetes Treatment and Management (9 papers). Arihiro Kiyosue is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Diabetes Treatment and Management (9 papers). Arihiro Kiyosue collaborates with scholars based in Japan, United States and Sweden. Arihiro Kiyosue's co-authors include Kohei Kaku, Jiro Ando, Issei Komuro, Takuto Tokudome, Shin‐ichiro Inoue, Satoshi Kodera, Yasunobu Hirata, Masao Takahashi, Ryozo Nagai and Anna Maria Langkilde and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Arihiro Kiyosue

65 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial

2023 71 citations Hiddo J.L. Heerspink, Arihiro Kiyosue et al. The Lancet profile →

Peers

Countries citing papers authored by Arihiro Kiyosue

Since Specialization

Citations

This map shows the geographic impact of Arihiro Kiyosue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arihiro Kiyosue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arihiro Kiyosue more than expected).

Fields of papers citing papers by Arihiro Kiyosue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arihiro Kiyosue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arihiro Kiyosue. The network helps show where Arihiro Kiyosue may publish in the future.

Co-authorship network of co-authors of Arihiro Kiyosue

This figure shows the co-authorship network connecting the top 25 collaborators of Arihiro Kiyosue. A scholar is included among the top collaborators of Arihiro Kiyosue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arihiro Kiyosue. Arihiro Kiyosue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of cardiac rehabilitation on progression to long-term care: A clinical and economic longitudinal study in Japan 2025 ·Journal of Cardiology ·Tomoyuki Takura, Arihiro Kiyosue, Teruyuki Koyama, (unknown), (unknown)	0
2	Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15 2024 ·Journal of Atherosclerosis and Thrombosis ·Shizuya Yamashita, Arihiro Kiyosue, Pierre Maheux, (unknown), Anastasia Lesogor, Qing Shao, Yuko Tamaki, (unknown), (unknown), Kouji Kajinami	14
3	Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial breakdown → 2023 ·The Lancet ·Hiddo J.L. Heerspink, Arihiro Kiyosue, David C. Wheeler, (unknown), (unknown), Glenn Carlson, (unknown), Magnus Åstrand, Sebastian Ueckert, Peter J. Greasley, Phil Ambery	71
4	Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events 2023 ·European Heart Journal ·(unknown), (unknown), (unknown), Taishi Nakamura, Kenichi Tsujita, (unknown), Takahide Kohro, Yusuke Oba, Tomoyuki Kabutoya, Yoichi Imai, Kazuomi Kario, Arihiro Kiyosue, Yuzo Mizuno, (unknown), Masaaki Nakayama	0
5	Asymptomatic myocardial infarction in a patient with myotonic dystrophy type 1 2022 ·Journal of Cardiology Cases ·(unknown), (unknown), Arihiro Kiyosue, Kôichi Kimura, Masae Uehara, Masaru Hatano, Takayoshi Sasako, Yuichiro Shirota, Atsushi Sudo, Hiroyuki Ishiura, Tatsushi Toda, Toshimasa Yamauchi, Issei Komuro	1
6	A Novel Technique of Balloon Pulmonary Angioplasty for the Treatment of Total Occlusion Lesions 2021 ·CJC Open ·Shun Minatsuki, Arihiro Kiyosue, Yu Shimizu, (unknown), (unknown), (unknown), Akihito Saito, Hiroki Yagi, Norifumi Takeda, Masaru Hatano, Jiro Ando, Issei Komuro	2
7	Histone methylation and demethylation are implicated in the transient and sustained activation of the interleukin-1β gene in murine macrophages 2020 ·Heart and Vessels ·Hiroyuki Imuta, Daishi Fujita, Shigeyoshi Oba, Arihiro Kiyosue, Hiroaki Nishimatsu, (unknown), Etsu Suzuki	6
8	Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension 2020 ·Journal of Cardiology ·Shun Minatsuki, Satoshi Kodera, Arihiro Kiyosue, Akihito Saito, Hisataka Maki, Masaru Hatano, Eiki Takimoto, Issei Komuro	12
9	Effectiveness of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension despite having lesion types suitable for surgical treatment 2019 ·Journal of Cardiology ·Shun Minatsuki, Arihiro Kiyosue, Satoshi Kodera, Toru Hara, Akihito Saito, Hisataka Maki, Masaru Hatano, Eiki Takimoto, Motomi Ando, Issei Komuro	21
10	OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia 2019 ·JACC CardioOncology ·Hiroyuki Kiriyama, Junichi Ishida, Hiroshi Kadowaki, Takeshi Iwasa, Arihiro Kiyosue, Satoshi Kodera, Jiro Ando, Hiroshi Akazawa, Issei Komuro	1
11	Efficacy and safety of alirocumab 150 mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON 2018 ·Journal of Cardiology ·Tamio Teramoto, Arihiro Kiyosue, Yasushi Ishigaki, Mariko Harada‐Shiba, Yumiko Kawabata, (unknown), Marie T. Baccara‐Dinet, Masataka Sata	14
12	Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge 2015 ·Journal of Cardiology ·Masamichi Ito, Kent Doi, Masao Takahashi, (unknown), (unknown), Yumiko Hosoya, Arihiro Kiyosue, Jiro Ando, Eisei Noiri, Naoki Yahagi, Yasunobu Hirata, Issei Komuro	13
13	Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease 2014 ·Heart and Vessels ·Masao Takahashi, (unknown), Aya Watanabe, Arihiro Kiyosue, Koichi Kimura, Jiro Ando, Yasunobu Hirata, Issei Komuro	5
14	Telmisartan Activates Endothelial Nitric Oxide Synthase via Ser1177 Phosphorylation in Vascular Endothelial Cells 2014 ·PLoS ONE ·(unknown), Daisuke Nagata, Daishi Fujita, Arihiro Kiyosue, Masao Takahashi, Hiroshi Satonaka, Yoshiyuki Morishita, Tetsu Akimoto, Ryozo Nagai, Issei Komuro, Yasunobu Hirata	15
15	Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study 2014 ·Diabetes Therapy ·Kohei Kaku, Hiroshi Maegawa, Yukio Tanizawa, Arihiro Kiyosue, Yumiko Ide, Takuto Tokudome, Yuji Hoshino, (unknown), Anna Maria Langkilde	57
16	Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease 2014 ·Heart and Vessels ·Daishi Fujita, Masao Takahashi, Kent Doi, Mitsuru Abe, Junichi Tazaki, Arihiro Kiyosue, (unknown), Jiro Ando, Hideo Fujita, Eisei Noiri, Takeshi Sugaya, Yasunobu Hirata, Issei Komuro	11
17	Hydrogen Peroxide Regulates Osteopontin Expression through Activation of Transcriptional and Translational Pathways 2013 ·Journal of Biological Chemistry ·Alicia N. Lyle, (unknown), (unknown), Bernard Lassègue, (unknown), Arihiro Kiyosue, Kathy K. Griendling, W. Robert Taylor	25
18	Aldosterone-induced osteopontin gene transcription in vascular smooth muscle cells involves glucocorticoid response element 2011 ·Hypertension Research ·Arihiro Kiyosue, Daisuke Nagata, (unknown), Tomohiko Sato, Masao Takahashi, Hiroshi Satonaka, Ryozo Nagai, Yasunobu Hirata	13
19	Prognostic implication of macrocytosis on adverse outcomes after coronary intervention 2011 ·Atherosclerosis ·(unknown), Hiroshi Iwata, Takahide Kohro, Hiroki Sato, Arihiro Kiyosue, Jiro Ando, Daigo Sawaki, Masao Takahashi, Hideo Fujita, Yasunobu Hirata, Ryozo Nagai	32
20	A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell 2009 ·Hypertension Research ·Daisuke Nagata, Arihiro Kiyosue, Masao Takahashi, Hiroshi Satonaka, Kimie Tanaka, Masataka Sata, Tetsuo Nagano, Ryozo Nagai, Yasunobu Hirata	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact